3rd Annual Digital Pharma Asia – Agenda

All timings are in SGT (UTC +8). Click here to convert to your timezone »

Day 1: 23 September 2020 | Wednesday


Opening Plenary


13:00
KEYNOTE ADDRESS:

From Cancer to COVID-19: Balancing Short & Long Term Corporate Goals, Engaging in New Collaborations & Building the Future of Digital Pharma

Dr. Andreas Schmidt, Chief Executive Officer, Proteona, Singapore/Germany

13:30
PHARMA LEADERS’ THINK TANK:
Redefining Pharma’s Role in the Global Healthcare Reform Agenda

  • COVID-19 vaccines candidate development
  • Regulations on pandemic drugs approval and accelerated clinical trials under diverse regimes
  • Future of pricing and affordability for Novel Drugs
  • Why technology should be the key component to surviving COVID-19?
  • AI and its immense potential in use of pandemic treatments and early detection

Moderator:
Christine Kuan, Board Director, Taiwan Cognitive Enhancement Association, Taiwan

Panellists:
Dr. Sucharita Das, Chief Consultant Regulatory, Quality and Clinical Trials Global/ APAC, Singapore
Edsel Pereira
, Group Vice President – Information Technology, Glenmark Pharmaceuticals, India
Alexander Zach
, Senior Vice President, Global Head of Market Access and Policy, Biocon, India
Dr. Keith Carpenter
, A*STAR Senior Fellow, Pharma Innovation Programme Singapore (PIPs), Singapore

14:10
Online Networking and Stretch Break


COVID-19 & A Digital Reset


15:00
DIGITAL PHARMA THOUGHT LEADERSHIP PANEL:
Reinventing Leadership in Pharma’s Digital Age

  • Rethinking innovations and resilient digital strategies amidst COVID-19
  • Other major issues facing digital transformation
  • Quantifying success of digital transformation
  • It takes a village: Importance of culture, and key characteristics of a “digital culture”
  • How to go about pulling the levers of cultural change and setting the right structures for digital transformation?

Moderator:
Geoff Wade, Chief Information Officer, AstraZeneca Asia, Singapore

Panelists:
Chandana Yeluri, Head- Digital and Continuous Improvement, Sandoz Development Center, Novartis, India
Sumeet Chandna, Head of Commercial Excellence, Learning and Digital, Cipla, India
Deepti Saraf, Chief Transformation Officer (Agile Transformation), Roche, Thailand
Regine Chung, Head of Digital Solutions, Novo Nordisk, China
Danielle Bateman, Head of Commercial and Digital IT, Growth and Emerging Markets, Takeda, Singapore

16:10
COVID-19 Case Study: The Promise and Challenge of Big Data for Pharma

  • Novel coronavirus (COVID-19) – Industry’s R&D efforts
  • Current applications of data science in novel drug R&D
  • Bottlenecks with the use of data in drug development
  • Why does pharma need a “data science mindset”?
  • How far are we from completely replacing clinical trial evidence with real-world data sources?

Dr. Takashi Moriya, Director, Data Sciences, Research & Development Division, Janssen Pharmaceutical K.K. (Japan)

16:40
How is Artificial Intelligence Changing Drug Discovery and Advanced R&D?

  • The digital response to COVID-19 and new investment drivers
  • Key AI areas and projects in healthcare and pharma
  • AI in Drug Discovery – Accelerating the development of new treatments
  • International collaboration as key component of the government’s AI innovation development strategy

George Tseng, CEO, All Vista Healthcare Sub-center, Ministry of Science and Technology (MOST) Joint Research Center for AI Technology and All Vista Healthcare, Taiwan

17:10
Tech Use in Trials, in the Case of COVID-19

  • Overview of digital tech opportunities for clinical trials
  • Recruitment for clinical and market research using digital health platforms
  • Redesigning and scaling up trials with IoT
  • Supply chain management with blockchain tech
  • Automated analyses and insights from big data with AI
  • Case Study: AskDr, a local digital solution initiated in response to COVID-19
  • Avenues for investments and co-development in digital health

Dr. Dinesh Visva Gunsekeran, Senior Lecturer (Medical Innovation), National University of Singapore, Physician Leader (Telemedicine), Raffles Medical Group, Singapore

17:40
Pharma Supply Chain and How Next-Gen Digital Applications will reshape SCM post COVID 19

  • Applications of analytics in Glenmark’s pharma supply chain outreach
  • Monitoring drug, and ingredients supply chain for impact of COVID-19 pandemic
  • COVID-19: Managing supply chain risk and disruption
  • Addressing track and trace compliance requirements: One of India pharma industry’s most critical challenges globally

Edsel Pereira, Group Vice President - Information Technology, Glenmark Pharmaceuticals, India

18:10
End of Virtual Conference Day 1

Day 2: 24 September 2020 | Thursday

13:00
Chairperson’s Opening Remarks


Tech Investments & Partnerships


13:00
INNOVATION THROUGH COLLABORATION ROUNDTABLE:
Understanding Collaboration in Unprecedented Times: The Corporate Perspective 

  • Why are VCs and corporate ventures courting digital health start-ups?
  • COVID-19: Start-ups excelling in a time of crisis
  • What do start-ups want from their corporate accelerator partners, and vice-versa?
  • When does a collaboration make sense for each of the parties involved?
  • Which questions need to be solved to collaborate successfully?

Moderator:
Augustus Loi, Senior Manager (Investments), SGInnovate, Singapore

Panelists:
Debashish Banerjee, Head- Innovation and Strategy, Novartis, India
Niclas Nilsson, Head of Open Innovation in Research, LEO Pharma A/S, Denmark
Dr. Sonali Khanra
, Head, OJAS MedTech BioNEST, CIE@IIITH (MedTech Incubator), India
Lana Ghanem, Managing Director, Hikma Ventures, Jordan
Edward Kilphuis, Investment Director, M Ventures, Spain

14:10
PHARMA INNOVATION PROGRAMME SINGAPORE (PIPS) CASE STUDY:
Accelerated Digital Innovation During COVID-19 and Beyond

  • PIPs’ views on COVID-19 – Investment potential, focused tech areas, and who is being engaged
  • Observed market trends and how is PIPs working with the private sector to leverage on and adapt to these trends
  • Some issues facing manufacturing and supply chains in digitization
  • COVID-19 and its impact on pharma supply chain and manufacturing
  • Rapid process development and introduction

Dr. Keith Carpenter, A*STAR Senior Fellow, Pharma Innovation Programme Singapore (PIPs), Singapore


Securing Digital Health


14:40
HEALTHCARE CYBERSECURITY LEADERS’ FORUM:
Cybersecurity, Privacy and Compliance in Pharma 4.0

  • Current threat scenarios and evolving threats in healthcare cybersecurity
  • What factors to consider in the process of implementing cybersecurity practices to “best fit” your organization?
  • Maintaining the strategic balance between innovation and compliance: Regulations as a boon or a bane for innovations?

Moderator:
Ramesh Raj, Regional Director – Asia Pacific, Pharmaceutical Security Institute, Singapore

Panelists:
Subhajit Deb, Chief Information Security Officer (CISO), Dr. Reddy’s Laboratories, India
Nitin Dhavate
, Country Head – Data Privacy (India and South Asia Cluster), Novartis, India
Christopher Ching
, Head of IT, Roche Singapore Technical Operations
Padmaraj Venkatappa, Head – Ethics, Risk and Compliance, Novartis Business Services – India

15:40
Online Networking and Stretch Break


PHARMA TECH START-UP SHOWCASE:
5 startups at the forefront of drug discovery and treatment R&D have been selected to pitch to a targeted audience of pharma manufacturers, biotechs, tech providers, VCs and investors.


16:10
Moderator’s Opening Remarks

Dr. Dinesh Visva Gunsekeran, Senior Lecturer (Medical Innovation), National University of Singapore, Physician Leader (Telemedicine), Raffles Medical Group, Singapore

16:20
Mesh Bio: Transforming Chronic Disease Management through Predictive Analytics

Dr. Andrew Wu, CEO and Co-Founder, Mesh Bio, Singapore 

16:35
Eko.ai.: Automating the Fight against Heart Disease

James Hare, CEO and Co-Founder, eKo.ai, Singapore

16:50
Medo.ai: Ultrasound + Artificial Intelligence: Enabling the stethoscope of the 21st century

Dr. Jeevesh Kapur, Senior Consultant and Assistant Professor in Radiology, National University Health System (NUHS), Co-Founder, Medo.ai

17:05
Qritive: Accelerate R&D: AI-powered histopathology

Rajasa Jialdasani, Medical Director, Qritive, Singapore

17:20
AskDr: Digitised marketing and distribution of therapeutic products

Brian Toh, Founder & CEO, AskDr, Singapore

17:35
Combined Live Q&A Session

17:55
End of Virtual Conference Day 2

Day 3: 25 September 2020 | Friday

13:00
Chairperson’s Opening Remarks

Dr. Aneesh Santhe, CEO and Co-Founder, Qritive, Singapore


Digitalising Consumer Engagement


13:10
How is Digital Tech Empowering the Self-Care Movement? 

  • How OTC market helps manage a pandemic?
  • Evolution of consumer-facing applications in the OTC market: From hospitals to smartphones, to home interconnections
  • Some use cases of wearables and mHealth applications in the OTC market
  • Digital strategies for improving OTC marketing success

Angela Brady, Director of Innovation Research, APAC R&D, GSK, Singapore          

13:40
Data-Driven Process Excellence – RPA in Pharma

  • Improving pharma workflows with better Process Management during pandemic crisis
  • Why process excellence matters to the pharma industry
  • Opportunities of business process management as a driver of innovation
  • Best practices for implementing process improvements
  • Some key process implementation pitfalls

Azuhar Mohammed, Head of Global Solution Center – Expertise & Innovation, Sanofi, Singapore  


DIGITAL TRANSFORMATION IN EMERGING MARKETS


14:10
Case Study: Development of Digital Distribution Channels in Indonesia

  • Trends in the retailing and distribution landscape
  • How did pharma distributors adjust to the COVID-19 pandemic?
  • Reengineering pharmaceutical networks for the digital era
  • E-commerce UI/UX design: Principles and Strategies

Agustina Siahaan, Head of IT, SOHO Global Health, Indonesia

14:40
Online Networking & Stretch Break

15:10
Establishing and Accelerating OTC Brand Growth in E-Commerce

  • Overview of e-commerce trends in the consumer healthcare sector
  • Current state of e-commerce infrastructure development and baseline establishment
  • Growth acceleration plan to win in consumer healthcare

Hesnuaril Marlindayani, Head of E-Commerce & Digital, Consumer Health Indonesia, PT Bayer Indonesia

15:40
Case Study: Orchestrated Customer Engagement in Vietnam: From CRM to the CLM

  • State of digital tools for customer engagement in Vietnam’s pharma market
  • Improving physician and patient engagement through Digital Journey Customer Mapping
  • How to develop an effective data flow management system and enhance targeted contents effectively for HCP activities

Danh Nguyen, Country Managing Director, Besins Healthcare, Vietnam


JOINT CLOSING PLENARY SESSION


16:20
DIVERSITY & INCLUSION IN PHARMA:

Cultivating the Next-Gen of Women Leaders in Pharma

  • Why does gender equality matter on the board?
  • Key challenges facing women leaders in Pharma
  • Management efforts to address some of these challenges, and remaining gaps
  • Reflections on the journey to the top
  • Breaking the glass ceiling: Lessons learnt along the way, and advice to my younger self
  • Management efforts to address some of these challenges, and remaining gaps

Moderator:
Sayantani Dasgupta, Former Associate Director, Customer Engagement Strategy & Commercial Excellence, Merck, Japan

Panelists:
Anupama Rao Singh, Business Head – LATAM | Head – Oncology and Institutional Business COE, Dr.Reddy’s Emerging Markets, Dr Reddys, India
Angela Brady
, Director of Innovation Research, APAC R&D, GSK, Singapore
Chandana Yeluri, Head- Digital and Continuous Improvement, Sandoz Development Center, Novartis, India
More panelists to be confirmed

17:10
End of Day 3 Virtual Conference